CureSearch is excited to announce that Sanofi will be sponsoring the 2024 Pediatric Early Development Symposium (PEDS). This virtual event, taking place on October 9th and 10th, will bring together leaders in entrepreneurship, regulatory affairs, investment strategies, academic research, and collaborative partnerships to address the challenges and opportunities within the pediatric cancer landscape. This year’s topics will facilitate critical conversations that propel new treatments towards regulatory approval and commercialization.
Dr. Peter Adamson, Global Development Therapeutic Area Head, Oncology and Pediatric Innovation at Sanofi, will lead the discussion on the role of public-private partnerships in pediatric cancer drug development:
Session 4: Partnering for Progress: Strategies for Engaging Investors in Pediatric Cancer Public-Private Partnerships
Celebrating its 50th anniversary in 2023, Sanofi has a storied history of driving innovations that enhance public health. They were the first global supplier of the injectable polio vaccine and have since developed the first vaccines for influenza, meningitis, and rabies. Sanofi’s oncology research and development team is committed to advancing treatments for those living with cancer today. Frank Nestle, Chief Scientific Officer, emphasizes their commitment: “We’re determined to develop powerful medicines that are effective and maintain the best possible safety profile for those living with cancer. We’re confident we can achieve this by leveraging our proprietary drug discovery platforms.”
To learn more about Sanofi, visit: Sanofi
For more on their oncology efforts, visit: Sanofi Oncology
A sincere thank you to Sanofi for supporting the 2024 PEDS as we unite with experts to advocate for lifesaving treatment options for kids with cancer.To register for 2024 PEDS, visit: curesearch.org/peds2024.
